Vitiligo - Part 1

AUTOR(ES)

Tarlé, Roberto Gomes, Nascimento, Liliane Machado do, Mira, Marcelo Távora, Castro, Caio Cesar Silva de

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2014-06

RESUMO

Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects melanocytes from epidermis basal layer, leading to the development of hypochromic and achromic patches. Its estimated prevalence is 0.5% worldwide. The involvement of genetic factors controlling susceptibility to vitiligo has been studied over the last decades, and results of previous studies present vitiligo as a complex, multifactorial and polygenic disease. In this context, a few genes, including DDR1, XBP1 and NLRP1have been consistently and functionally associated with the disease. Notwithstanding, environmental factors that precipitate or maintain the disease are yet to be described. The pathogenesis of vitiligo has not been totally clarified until now and many theories have been proposed. Of these, the autoimmune hypothesis is now the most cited and studied among experts. Dysfunction in metabolic pathways, which could lead to production of toxic metabolites causing damage to melanocytes, has also been investigated. Melanocytes adhesion deficit in patients with vitiligo is mainly speculated by the appearance of Köebner phenomenon, recently, new genes and proteins involved in this deficit have been found.

Documentos Relacionados

• Vitiligo - Part 2 - classification, histopathology and treatment
• The emerging role of business plans for veterinarians — Part 1
• Common long bone fractures in small animal practice — Part 1
• Fortifying pork liver mixture: preparation and physicochemical characteristics - Part 1
• Periprosthetic Knee Infection - Part 1: Risk Factors, Classification and Diagnosis